Finance

Lists
SBFM:NASDAQ
Sunshine Biopharma Inc
USD 2,75
+1,48%
(+0,040) 1D
USD 2,75
-0,11% (-0,0029)
Pre-market
Closed: 9 Nov., 16:00:00 GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for SBFM...
Open
USD 2,76
High
USD 2,82
Low
USD 2,70
Mkt. cap
2,09 m
Avg. vol.
609,38 k
Volume
155,00
52-wk high
USD 464,00
52-wk low
USD 2,53
EPS
-USD 200,66
Beta
1,54
Shares outstanding
761,00 k
No. of employees
50
Open
USD 2,76
High
USD 2,82
Low
USD 2,70
Mkt. cap
2,09 m
Avg. vol.
609,38 k
Volume
155,00
52-wk high
USD 464,00
52-wk low
USD 2,53
EPS
-USD 200,66
Beta
1,54
Shares outstanding
761,00 k
No. of employees
50
News stories
From web sources and news partners
About Sunshine Biopharma Inc
CEO-
Employees50
Founded2006
HeadquartersFort Lauderdale, Florida, Verenigde State van Amerika
SectorHealth Care
Industry-
Websitesunshinebiopharma.com
Analyst
Recommendation
Action
Price target
Projected
Date
No analyst ratings found.
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
9,42 m
8,58 m
8,09 m
9,26 m
Cost of goods sold
6,34 m
5,55 m
5,91 m
6,84 m
Cost of revenue
6,34 m
5,55 m
5,91 m
6,84 m
Research and development expenses
119,30 k
73,50 k
31,72 k
13,22 k
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3,27 m
4,39 m
3,34 m
3,81 m
Operating expense
3,61 m
4,69 m
3,58 m
4,04 m
Total operating expenses
9,95 m
10,24 m
9,48 m
10,88 m
Operating income
-531,96 k
-1,66 m
-1,40 m
-1,61 m
Other non operating income
-
-
103,32 k
-
EBT including unusual items
-1,02 m
-1,73 m
-1,24 m
-1,56 m
EBT excluding unusual items
-456,36 k
-1,60 m
-1,24 m
-1,56 m
Income tax expense
-137,44 k
408,37 k
-
-
Effective tax rate
13,46%
-23,57%
-
-
Other operating expenses
119,91 k
126,54 k
129,66 k
138,49 k
Net income
-883,82 k
-2,14 m
-1,24 m
-1,56 m
Net profit margin
-9,39%
-24,96%
-15,38%
-16,88%
Earnings per share
-
-
-
-
Interest and investment income
75,35 k
57,47 k
48,43 k
48,82 k
Interest expense
-
-
-
-
Net interest expenses
75,35 k
57,47 k
48,43 k
48,82 k
Depreciation and amortization charges
95,82 k
98,92 k
76,86 k
77,97 k
EBITDA
-435,80 k
-1,56 m
-1,32 m
-1,53 m
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google-programme